These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 728237)

  • 21. Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia.
    Deckelbaum RJ; Lees RS; Small DM; Hedberg SE; Grundy SM
    N Engl J Med; 1977 Mar; 296(9):465-70. PubMed ID: 834224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
    [No Abstract]   [Full Text] [Related]  

  • 23. The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia.
    Howard AN; Hyams DE; Evans C
    Adv Exp Med Biol; 1972; 26(0):179-87. PubMed ID: 4679724
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ; Tsang RC; Fallat RW; Mellies M
    Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma exchange in a patient with heterozygous familial hypercholesterolaemia resistant to drug therapy.
    Eriksson M; Lantz B; Berglund L; Angelin B
    Acta Med Scand; 1987; 221(3):317-20. PubMed ID: 3591471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of clofibrate in familial hypercholesterolemia.
    Pichardo R; Boulet L; Davignon J
    Atherosclerosis; 1977 Apr; 26(4):573-82. PubMed ID: 193524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin].
    Gavelli MS; Vitaliano E; Serra T; Rossi FG; Rizzuti A; Caridis R; Tozzi J
    Clin Ter; 1990 May; 133(3):145-50. PubMed ID: 2142901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
    Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.
    Grundy SM
    J Clin Invest; 1975 Feb; 55(2):269-82. PubMed ID: 233943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
    Wilke H; Frahm H
    Dtsch Med Wochenschr; 1976 Mar; 101(11):401-5. PubMed ID: 1253701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypolipidemic drugs and hyperlipoproteinemia.
    Levy RI; Langer T
    Ann N Y Acad Sci; 1971 Jul; 179():475-80. PubMed ID: 4941915
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia.
    Farah JR; Kwiterovich PO; Neill CA
    Lancet; 1977 Jan; 1(8002):59-63. PubMed ID: 63709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K; Einarsson K
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of long-term plasma exchange for familial hypercholesterolaemia.
    Thompson GR; Myant NB; Kilpatrick D; Oakley CM; Raphael MJ; Steiner RE
    Br Heart J; 1980 Jun; 43(6):680-8. PubMed ID: 7426147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid.
    Carlson LA; Danielson M; Ekberg I; Klintemar B; Rosenhamer G
    Atherosclerosis; 1977 Sep; 28(1):81-6. PubMed ID: 911371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture.
    Keller C; Hailer S; Demant T; Wolfram G; Zöllner N
    Atherosclerosis; 1985 Nov; 57(2-3):225-34. PubMed ID: 4084356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
    Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
    Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.